Erasca, Inc. (ERAS)
14.14
-0.16
(-1.12%)
USD |
NASDAQ |
Oct 07, 16:00
14.14
0.00 (0.00%)
After-Hours: 20:00
Erasca EPS Diluted (Quarterly) : -0.1416 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1416 |
| March 31, 2026 | -0.6028 |
| December 31, 2025 | -0.1025 |
| September 30, 2025 | -0.1079 |
| June 30, 2025 | -0.1196 |
| March 31, 2025 | -0.1093 |
| December 31, 2024 | -0.114 |
| September 30, 2024 | -0.1105 |
| June 30, 2024 | -0.2902 |
| March 31, 2024 | -0.2316 |
| December 31, 2023 | -0.197 |
| September 30, 2023 | -0.2018 |
| June 30, 2023 | -0.2118 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.2221 |
| December 31, 2022 | -1.060 |
| September 30, 2022 | -0.2938 |
| June 30, 2022 | -0.2962 |
| March 31, 2022 | -0.3051 |
| December 31, 2021 | -0.2564 |
| September 30, 2021 | -0.38 |
| June 30, 2021 | -0.2328 |
| March 31, 2021 | -0.1515 |
| December 31, 2020 | -0.5204 |
| September 30, 2020 | -0.0875 |
| June 30, 2020 | -0.0462 |
| March 31, 2020 | -0.1989 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Twist Bioscience Corp. | -0.5617 |
| Immunome, Inc. | -0.6456 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.08M |
| Total Expenses (Quarterly) | 44.08M |
| Enterprise Value | 4.246B |
| Earnings Yield | -6.75% |
| Normalized Earnings Yield | -4.277 |